<b>Consenso de expertos mexicanos acerca de la profilaxis a largo plazo en pacientes con angioedema hereditario en México</b>

HAE prophylaxis management in Mexico appears aligned with contemporary standards, yet sustained and individualized implementation remains limited by structural access and supply constraints. Key priorities include strengthening timely diagnosis, ensuring continuous access to targeted therapies, and standardizing follow-up in routine clinical care.